Medtronic Lawsuit

The FDA announced that it saw a higher rate of death among patients with abdominal aortic aneurysms who were treated with a Medtronic device than with traditional surgery after 5 years.

 The FDA announced, in a public health notification on their website, that the Medtronic AneuRx stent-graft device is the only item being studied because it is the only device on the market that has a significant number of patients who have been followed for at least five years after receiving a device.

 The device is inserted via a vein in the leg to prevent blood vessels in the abdomen from rupturing. If an aneurysm bursts, the condition can be fatal. Swollen blood vessels can be treated with conventional surgery as well.

If you have been given a Medtronic ICD with Sprint Fidelis leads, contact the Medtronic lawyers of Williams Kherkher at 1-866-950-9000 to discuss your case and to determine your legal options.